Out of the 49 analysts covering SBI, 39 have a 'Buy' rating, six recommend 'Hold,' and four have a 'Sell' rating on the stock ...
Aurobindo Pharma’s Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback